gabexate has been researched along with Adenocarcinoma, Papillary in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manabe, T | 1 |
| Asano, N | 1 |
| Yoshimura, T | 1 |
| Suwa, H | 1 |
| Imamura, T | 1 |
| Ohshio, G | 1 |
1 other study available for gabexate and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Effect of synthetic protease inhibitor on histologic changes and free radical activity in hamsters with pancreatic cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Carcinogens; Cricetinae; Esters; Free Radical Sc | 1993 |